Recombinant Human CD152/CTLA4 Protein, C-His (HB651011)

Datasheet Share product Copy info

Price(USD): $

Spec:

50ug
100ug
1mg

Number:

Overview
Images
References
Datasheet

Overview

Catalog No.	HB651011
Description	Recombinant Human CD152/CTLA4 Protein, C-His (HB651011) expressed in Mammalian Cells, spanning Met1-Asp161. Purity: >90% by SDS-PAGE. Highlights ●His-Tagged — N-terminal 6×His tag for IMAC purification. ●Mammalian Expression — Proper folding and native glycosylation. ●High Purity — >90% purity verified by SDS-PAGE.
Expression system	Mammalian Cells
Accession	P16410
Protein length	Met1-Asp161
Applications	ELISA, Immunogen, SDS-PAGE, WB, Bioactivity testing in progress
Species	Homo sapiens (Human)
Nature	Recombinant
Endotoxin level	Please contact with the lab for this information.
Purity	>90% as determined by SDS-PAGE.
Predicted molecular weight	18.55 kDa
Form	Lyophilized
Storage buffer	Lyophilized from a solution in PBS pH 7.4, 1 mM EDTA, 4% Trehalose, 1% Mannitol. Please refer to the specific buffer information in the hardcopy of datasheet or the lot-specific COA.
Reconstitution	Reconstitute in sterile water for a stock solution. Adjust the volume of sterile water so that, after reconstitution, the final stock concentration matches the value indicated on the product label or datasheet. RECONSTITUTION PROTOCOL 1. Allow the product to be reconstituted and the reconstitution diluent to reach room temperature. 2. Tap or briefly centrifuge the product vial before opening to dislodge any lyophilized material that may be dispersed on the wall or cap of the vial. 3. Use the diluent and stock concentration recommended in the product datasheet. If preparing a stock concentration higher than recommended, contact Technical Service. 4. After adding the diluent, re-cap the vial and invert gently by hand or place on a slow rocking platform to allow the reconstitution diluent to coat all the surfaces inside the vial. Note: Do not mix by vortexing or by pipetting the material up and down. 5. Allow the vial to sit at room temperature with gentle agitation for at least 15 minutes before aliquotting or using. 6. Store the reconstituted material in single use aliquots in polypropylene or siliconized tubes. Aliquots of 10 μL or larger are recommended.
Shipping	In general, proteins are provided as lyophilized powder/frozen liquid. They are shipped out with dry ice/blue ice unless customers require otherwise.
Stability and Storage	Use a manual defrost freezer and avoid repeated freeze thaw cycles. Store at 2 to 8°C for frequent use. Store at -20 to -80°C for twelve months from the date of receipt.
Alternate Names	CD152, Cytotoxic T-lymphocyte protein 4, CTLA-4, CTLA4, Cytotoxic T-lymphocyte-associated antigen 4
Background	Cytotoxic T-lymphocyte protein 4 (CD152/CTLA4) is a ~24 kDa protein. Inhibitory receptor acting as a major negative regulator of T-cell responses. Acts as a decoy receptor: the affinity of CTLA4 for its natural B7 family ligands, CD80 and CD86, is considerably stronger than the affinity of their cognate stimulatory coreceptor CD28. CD152 is the therapeutic target of ipilimumab (Yervoy). 1. Schwartz, JC. et al. (2001) Nature 410, 604-8. PMID: 11279501 2. Stamper, CC. et al. (2001) Nature 410, 608-11. PMID: 11279502 3. Teft, WA. et al. (2006) Annual review of immunology 24, 65-97. PMID: 16551244 4. Linsley, PS. et al. (1991) The Journal of experimental medicine 174, 561-9. PMID: 1714933 5. Zheng, Y. et al. (2008) Journal of immunology (Baltimore, Md. : 1950) 181, 1683-91. PMID: 18641304 6. Ramagopal, UA. et al. (2017) Proceedings of the National Academy of Sciences of the United States of America 114, E4223-E4232. PMID: 28484017
Note	For research use only.

Images

SDS-PAGE

SDS-PAGE for Recombinant Human CD152/CTLA4 Protein, C-His
Bioactivity

Detects Human CD152/CTLA4 Antibody in indirect ELISAs.
Bioactivity

Detects Ipilimumab in indirect ELISAs.
Bioactivity

Detects Nurulimab in indirect ELISAs.
Bioactivity

Detects Cadonilimab in indirect ELISAs.
Bioactivity

Detects Botensilimab in indirect ELISAs.
Bioactivity

Detected by Research Grade Gotistobart (Cat No.: HB651266) in indirect ELISA.
Western blot

Detected by Anti-CD152/CTLA4 monoclonal antibody (Catalog No: HS870396)
Bioactivity

Detected by Research Grade Quavonlimab (Catalog No: HB651066) in indirect ELISA
Bioactivity

Detected by Anti-Human CD152/CTLA4 Antibody (HL32) (Catalog No: HB651407) in indirect ELISA
Bioactivity

Detected by SAA1104 (Catalog No: HB651013) in indirect ELISA.
Bioactivity

Detected by Pavunalimab (Catalog No: HB613086) in indirect ELISA.
Bioactivity

Detected by Lorigerlimab (Catalog No: HB651086) in indirect ELISA.
Bioactivity

Detected by Tuvonralimab (Catalog No: HB651096) in indirect ELISA.
Bioactivity

Detected by Porustobart (Catalog No: HB651246) in indirect ELISA.
Bioactivity

Detected by Firastotug (Catalog No: HB651256) in indirect ELISA.
Bioactivity

Detected by Muzastotug (Catalog No: HB651276) in indirect ELISA.
Bioactivity

Detected by Sovipostobart (Catalog No: HB651286) in indirect ELISA.
Bioactivity

Detected by Evalstotug (Catalog No: HB651296) in indirect ELISA.
Bioactivity

Detected by Vilastobart (Catalog No: HB651306) in indirect ELISA.
Bioactivity

Detected by Tazlestobart (Catalog No: HB651316) in indirect ELISA.